Accumulating evidence has revealed the therapeutic potential of unmethylated CpG motif in DNA, a ligand for the Toll-like receptor (TLR)9 in endosome as an immune-stimulatory adjuvant for the treatment of cancer and infectious diseases (20–24). Here, TLR9 is linked to cancer.